(R)-2-methoxy-4-(4-methyl-2-oxooxazolidin-3-yl)benzoic acid → (R)-3-{4-[4-(3,5-dimethylpyridin-2-yl)piperazine-1-carbonyl]-3-methoxyphenyl}-4-methyloxazolidin-2-one hydrochloride
Reaction equation
[CH3:1][O:2][C:3]1[CH:11]=[C:10]([N:12]2[C@H:16]([CH3:17])[CH2:15][O:14][C:13]2=[O:18])[CH:9]=[CH:8][C:4]=1[C:5]([OH:7])=O.[ClH:19].[CH3:20][C:21]1[C:22]([N:28]2[CH2:33][CH2:32][NH:31][CH2:30][CH2:29]2)=[N:23][CH:24]=[C:25]([CH3:27])[CH:26]=1>>[ClH:19].[CH3:20][C:21]1[C:22]([N:28]2[CH2:29][CH2:30][N:31]([C:5]([C:4]3[CH:8]=[CH:9][C:10]([N:12]4[C@H:16]([CH3:17])[CH2:15][O:14][C:13]4=[O:18])=[CH:11][C:3]=3[O:2][CH3:1])=[O:7])[CH2:32][CH2:33]2)=[N:23][CH:24]=[C:25]([CH3:27])[CH:26]=1Participants
3
Procedure
By reaction and treatment in the same manner as in Example 87 and using (R)-2-methoxy-4-(4-methyl-2-oxooxazolidin-3-yl)benzoic acid (1.1 g) described in Preparation Example 45 and 1-(3,5-dimethylpyridin-2-yl)piperazine hydrochloride (956 mg) described in Preparation Example 64, the title compound (731 mg) was obtained.
Workup
- customBy reaction and treatment in the same manner as in Example 87
- customdescribed in Preparation Example 64
Sources & evidence
- ORD record
- ord-5121c145ef64449aa36863d5d889b4ac
- Source dataset
- uspto-grants-2013_01
- Patent number
- US08354401B2
Reaction notes
Loading…